Dr Lal PathLabs Ltd. is India’s leading diagnostic laboratory and pathology services provider. It was established in 1949 by Dr S.K. Lal and is headquartered in New Delhi. The company operates a network of over 2000 collection centers and more than 200 laboratories and provides services in over 300 cities and towns across India.
The company offers a wide range of clinical laboratory tests and services, including biochemical tests, immunological tests, microbiology tests, hematology tests, histopathology tests, cytology tests, and molecular diagnostics tests. It also provides a variety of preventive health checkup packages.
Dr Lal PathLabs has a strong presence in the online space and offers services such as online booking and test results, online payment, and home sample collection. The company is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
Recently Dr Lal Path Labs shared its Q4Fy2024 results, and the growth looks impressive. This post will discuss more about Dr LalPathLabs and its share price target for 2024 to 2030 through 2025.
Dr Lal PathLabs Q4 FY24 Financial Highlights
- Dr Lal PathLabs reported strong Q4 FY24 results, with revenue increasing by 11% to ₹545.5 crore compared to ₹491 crore in the same period last year.
- The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) saw a significant rise of 25.2% to ₹144.7 crore, up from ₹115.6 crore in the corresponding quarter of FY23.
- Net profit for the fourth quarter surged by an impressive 49%, reaching ₹84.5 crore compared to ₹56.7 crore in the previous year.
- Dr Lal PathLabs announced a dividend of ₹6 per equity share, demonstrating confidence in its financial position and commitment to shareholder value.
- Margin performance also improved, with margins standing at 26.5% compared to 23.5% in the same period last year, highlighting the company’s operational efficiency and financial strength.
You can buy shares of Dr Lal PathLabs on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). You can buy shares through a stockbroker or an online trading platform.
To buy shares of Dr Lal PathLabs through a stockbroker, you must open a Demat and trading account with the stockbroker. You will have to fill out an account opening form, provide KYC documents, and submit the form with the required fees. Once you have opened the account, you can place an order to buy the shares of Dr Lal PathLabs.
Some online platforms to buy Lal PathLabs Stock are Zerodha, Upstox, 5Paisa, HDFC Securities, Angel Broking, ICICI Direct, Kotak Securities, etc.
| When | Maximum Price | Minimum Price |
| May 2024 | 2,361.30 | 2,053.31 |
| June 2024 | 2,446.31 | 2,127.23 |
| July 2024 | 2,421.85 | 2,105.95 |
| August 2024 | 2,518.72 | 2,190.19 |
| September 2024 | 2,619.47 | 2,277.80 |
| October 2024 | 2,568.11 | 2,233.14 |
| November 2024 | 2,670.83 | 2,322.46 |
| December 2024 | 2,697.54 | 2,345.69 |
In May 2024, Dr Lal PathLabs shares are projected to trade between ₹2,361.30 and ₹2,053.31, reflecting potential fluctuations in the market. As we progress through the year, the maximum and minimum prices are expected to vary, with June witnessing prices ranging from ₹2,446.31 to ₹2,127.23. July is anticipated to see prices fluctuating between ₹2,421.85 and ₹2,105.95. August is likely to experience a further increase, with prices estimated to range from ₹2,518.72 to ₹2,190.19. September and October are expected to follow similar trends, with prices gradually increasing. By December, Dr Lal PathLabs shares are projected to peak with a maximum price estimated at ₹2,697.54 and a minimum price of ₹2,345.69.
| When | Maximum Price | Minimum Price |
| January 2025 | 2,724.52 | 2,095.78 |
| February 2025 | 2,752.04 | 2,116.95 |
| March 2025 | 2,809.83 | 2,161.41 |
| April 2025 | 2,782.01 | 2,140.01 |
| May 2025 | 2,700.98 | 2,077.68 |
| June 2025 | 2,822.52 | 2,171.17 |
| July 2025 | 2,767.18 | 2,128.60 |
| August 2025 | 2,852.76 | 2,194.43 |
| September 2025 | 2,887.00 | 2,220.77 |
| October 2025 | 2,962.06 | 2,278.51 |
| November 2025 | 3,036.11 | 2,335.47 |
| December 2025 | 3,172.74 | 2,440.57 |
As we step into January 2025, Dr Lal PathLabs shares are expected to trade between ₹2,724.52 and ₹2,095.78, reflecting potential market fluctuations. Continuing into February, prices are projected to range from ₹2,752.04 to ₹2,116.95. March may see a further increase, with prices anticipated to fluctuate between ₹2,809.83 and ₹2,161.41. The trend is expected to continue throughout the year, with prices gradually increasing month by month. By December, Dr Lal PathLabs shares are forecasted to reach their peak, with a maximum price estimated at ₹3,172.74 and a minimum price of ₹2,440.57.
| When | Maximum Price | Minimum Price |
| January 2026 | 3,267.92 | 2,513.78 |
| February 2026 | 3,186.22 | 2,450.94 |
| March 2026 | 3,249.94 | 2,499.96 |
| April 2026 | 3,316.27 | 2,550.98 |
| May 2026 | 3,283.43 | 2,525.72 |
| June 2026 | 3,365.52 | 2,588.86 |
| July 2026 | 3,299.53 | 2,538.10 |
| August 2026 | 3,401.58 | 2,616.60 |
| September 2026 | 3,469.61 | 2,668.93 |
| October 2026 | 3,559.82 | 2,738.32 |
| November 2026 | 3,648.81 | 2,806.78 |
| December 2026 | 3,740.03 | 2,876.95 |
| When | Maximum Price | Minimum Price |
| January 2027 | 3,777.43 | 2,905.72 |
| February 2027 | 3,874.29 | 2,980.22 |
| March 2027 | 4,025.39 | 3,096.45 |
| April 2027 | 3,946.46 | 3,035.74 |
| May 2027 | 3,831.51 | 2,947.32 |
| June 2027 | 4,003.93 | 3,079.95 |
| July 2027 | 3,925.42 | 3,019.56 |
| August 2027 | 4,046.83 | 3,112.95 |
| September 2027 | 4,188.47 | 3,221.90 |
| October 2027 | 4,297.37 | 3,305.67 |
| November 2027 | 4,404.80 | 3,388.31 |
| December 2027 | 4,514.92 | 3,473.02 |
| When | Maximum Price | Minimum Price |
| January 2028 | 4,605.22 | 3,542.48 |
| February 2028 | 4,723.30 | 3,633.31 |
| March 2028 | 4,907.51 | 3,775.01 |
| April 2028 | 4,811.29 | 3,700.99 |
| May 2028 | 4,671.15 | 3,593.19 |
| June 2028 | 4,881.35 | 3,754.89 |
| July 2028 | 4,785.64 | 3,681.26 |
| August 2028 | 4,933.65 | 3,795.12 |
| September 2028 | 5,106.33 | 3,927.95 |
| October 2028 | 5,239.09 | 4,030.07 |
| November 2028 | 5,370.07 | 4,130.82 |
| December 2028 | 5,504.32 | 4,234.09 |
| When | Maximum Price | Minimum Price |
| January 2029 | 5,614.41 | 4,318.78 |
| February 2029 | 5,758.37 | 4,429.51 |
| March 2029 | 5,982.94 | 4,602.26 |
| April 2029 | 5,865.63 | 4,512.02 |
| May 2029 | 5,694.79 | 4,380.61 |
| June 2029 | 5,951.05 | 4,577.73 |
| July 2029 | 5,834.37 | 4,487.97 |
| August 2029 | 6,014.81 | 4,626.78 |
| September 2029 | 6,225.33 | 4,788.71 |
| October 2029 | 6,387.19 | 4,913.22 |
| November 2029 | 6,546.87 | 5,036.05 |
| December 2029 | 6,710.54 | 5,161.95 |
| When | Maximum Price | Minimum Price |
| January 2030 | 6,844.75 | 5,265.19 |
| February 2030 | 7,020.26 | 5,400.20 |
| March 2030 | 7,294.05 | 5,610.80 |
| April 2030 | 7,151.03 | 5,500.79 |
| May 2030 | 6,942.74 | 5,340.57 |
| June 2030 | 7,255.17 | 5,580.90 |
| July 2030 | 7,112.91 | 5,471.47 |
| August 2030 | 7,332.90 | 5,640.69 |
| September 2030 | 7,589.55 | 5,838.11 |
| October 2030 | 7,786.87 | 5,989.90 |
| November 2030 | 7,981.55 | 6,139.65 |
| December 2030 | 8,181.09 | 6,293.14 |
As we move into January 2030, Dr Lal PathLabs shares are projected to trade between ₹6,844.75 and ₹5,265.19, indicating potential market fluctuations. Heading into February, prices are expected to range from ₹7,020.26 to ₹5,400.20, showing a likely upward trend. March may see a further increase, with prices anticipated to fluctuate between ₹7,294.05 and ₹5,610.80. The trend of rising prices is expected to continue throughout the year, culminating in December with Dr Lal PathLabs shares reaching their peak, with a maximum price estimated at ₹8,181.09 and a minimum price of ₹6,293.14.
Lal PathLabs Financial Condition: Last 5 years
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
| Sales + | 1,330 | 1,581 | 2,087 | 2,017 | 2,227 |
| Expenses + | 987 | 1,145 | 1,526 | 1,527 | 1,617 |
| Operating Profit | 344 | 436 | 561 | 490 | 609 |
| OPM % | 26% | 28% | 27% | 24% | 27% |
| Other Income + | 55 | 51 | 52 | 42 | 69 |
| Interest | 15 | 16 | 30 | 38 | 29 |
| Depreciation | 73 | 77 | 108 | 150 | 144 |
| Profit before tax | 310 | 394 | 475 | 344 | 506 |
| Tax % | 27% | 25% | 26% | 30% | 28% |
| Net Profit + | 228 | 296 | 350 | 241 | 362 |
| EPS in Rs | 27.11 | 34.99 | 41.37 | 28.65 | 42.85 |
| Dividend Payout % | 44% | 57% | 29% | 21% | 56% |
- Sales exhibited consistent growth over the years, increasing from ₹1,330 crore in March 2020 to ₹2,227 crore in March 2024.
- Operating profit also showed an upward trend, reaching ₹609 crore in March 2024, with an operating profit margin (OPM) fluctuating between 24% and 28%.
- Other income remained relatively stable, with a slight increase from ₹55 crore in March 2020 to ₹69 crore in March 2024.
- Interest expenses varied, peaking at ₹38 crore in March 2023 before decreasing to ₹29 crore in March 2024.
- Depreciation costs increased steadily over the years, reaching ₹144 crore in March 2024.
- Profit before tax fluctuated, reaching its highest point of ₹506 crore in March 2024.
- The effective tax rate remained relatively consistent, hovering around 25% to 30%.
- Net profit saw significant growth over the period, rising from ₹228 crore in March 2020 to ₹362 crore in March 2024.
- Earnings per share (EPS) also increased steadily, reaching ₹42.85 in March 2024.
- The dividend payout percentage fluctuated but remained substantial, ranging from 21% to 57% over the years.
FAQs
Will Lal PathLabs Stock price grow in 2024?
The stock price of Dr. Lal PathLabs in 2024 is subject to fluctuations, with projected price targets ranging from ₹2,053.31 to ₹ 2,697.54.
What is the market cap of Dr Lal PathLabs?
As of May 10th, 2024, the market capitalization of Dr Lal PathLabs is 19,597 Cr.
What future is anticipated for Dr Lal PathLabs in 2025?
In 2025, Dr. Lal PathLabs is anticipated to experience fluctuations in its stock price, with the potential for both highs and lows throughout the year, including a maximum price target of ₹3,172.74 in December.
Can Dr. Lal PathLabs reach 10,000 INR?
It is possible that the stock price of Dr. Lal PathLabs could reach 10,000 INR in the year 2031 or 2032.
However, it is impossible to predict exactly when this may happen as the stock price depends on several factors such as the company’s financial performance, market conditions, and investor sentiment. Investing in Dr Lal PathLabs shares could be a good option to generate returns.
The share price target for Dr. Lal PathLabs in 2030 indicates substantial growth potential, with the maximum price projected to be ₹8,181.09, suggesting a positive long-term trajectory.
Also Read
In Conclusion, Dr Lal PathLabs’ Q4 FY24 results portray a promising outlook for the company’s future trajectory. With a robust 11% increase in revenue compared to the previous year and a significant 25.2% rise in EBITDA, the company demonstrates resilience and operational strength. Moreover, the impressive surge of 49% in net profit underscores its efficient financial management and strategic positioning in the market. The announcement of a dividend of ₹6 per equity share further accentuates the company’s commitment to shareholder value. Dr Lal PathLabs’ consistent margin performance improvement reflects its operational efficiency and bodes well for sustained growth in the upcoming quarters. Overall, these results affirm Dr Lal PathLabs’ position as a leader in India’s diagnostic industry, instilling confidence in investors and stakeholders alike.
Amidst this, the company’s strategic focus on online services and proactive initiatives positions it for sustained success. The share price targets for 2024-2030 indicate a blend of short-term market dynamics and long-term growth potential. Dr Lal PathLabs, with its solid market presence, digital advancements, and historical financial stability, remains a key player in shaping the future of diagnostic healthcare in India.
Linkedin
